Food allergy discovery could pave way for new treatments
- A recent study in mice has identified an innovative strategy to potentially manage food allergy risk by targeting essential immune cells in the intestine.
- The research found that a specific population of cells, called RORγt+ dendritic cells, play a crucial role in preventing food allergies by presenting harmless food particles to the immune system and instructing T cells to remain unresponsive.
- Mice lacking these cells exhibited signs of allergic lung inflammation, while those with them did not, suggesting that targeting this cell population could prevent food allergies.
- The discovery has sparked hope for developing new treatments to manage food allergies, which affect approximately 30 million Americans and can have life-threatening consequences.
- Researchers plan to explore the potential of supporting the activity of RORγt+ dendritic cells as a therapy to prevent or treat food allergies, offering a promising new approach to managing this growing public health issue.
A study in mice reveals an innovative strategy to potentially manage food allergy risk.
Most of the time, the intestinal immune system can recognize friend from foe, tolerating myriad foods while destroying disease-causing invaders.
But for approximately 30 million Americans with food allergies—including 4 million children—immune cells mistakenly identify food as a threat, triggering potentially life-threatening reactions.
Now, researchers have identified, in mice, that essential immune cells in the intestine prevent an unwarranted attack against harmless food allergens.
In the absence of such cells, mice experienced gut inflammation and an allergic response to food.
The research appears in Cell.
“We are seeing a rapid global increase in food allergies that significantly impact quality of life,” says Marco Colonna, a professor of pathology at the Washington University School of Medicine in St. Louis.
“The lack of therapeutics to prevent and manage food allergies complicates the growing public health issue. Now that we know the players that establish tolerance to food allergens, we can devise innovative strategies to target them therapeutically and potentially prevent or treat food allergies.”
The immune system encounters common food allergens—peanuts, tree nuts, milk, eggs, and shellfish, among others—without launching a self-sabotaging immune attack in a process called tolerance. Broken tolerance to food triggers an allergic reaction with symptoms ranging from mild hives and itching to a severe, life-threatening allergic reaction that can cause throat swelling and difficulty breathing and requires immediate treatment.
As part of the current study, the researchers aimed to home in on the players working to prevent such reactions, in work that may help develop preventive treatments for food allergies.
Tolerance to food involves multiple immune cells. Certain immune cells pick up food particles, chop them into fragments and present them to the immune system’s T cells, instructing those cells to remain unresponsive to the harmless intruder. More recently, a small population of cells—the RORγt+ dendritic cells—has been found among the gut’s presenting immune cells in multiple species. Colonna’s lab was the first to identify the cells in people in 2023. Their role in preventing food allergies had not been explored.
Patrick Rodrigues, a postdoctoral scholar, and Shitong Wu, an MD/PhD student, in Colonna’s lab and the study’s co-first authors, set out to understand whether RORγt+ dendritic cells are the gut’s immune cells that prevent food allergies.
They treated mice with ovalbumin, a highly allergenic protein found in egg whites, orally and then intranasally. Mice lacking gut RORγt+ dendritic cells showed signs of allergic lung inflammation, while mice with these cells did not. An analysis of the gut immune cells found an imbalance among the T cells that trigger versus dampen immune responses to food particles in the allergic mice, with a skewing toward the former.
“By removing RORγt+ dendritic cells from the gut in mice, we broke tolerance to food allergens,” says Rodrigues.
“The discovery is now inspiring us to see if we can do the opposite: prevent food allergies by supporting the activity of this cell population. Because RORγt+ dendritic cells are found in people, our finding presents an exciting new possibility to manage food allergies and other gut-related immune diseases such as celiac disease or inflammatory bowel disease.”
Recently, the FDA approved an injectable medication, that, if administered continuously, helps prevent an allergic response to accidental exposure to small amounts of allergens by blocking the antibodies that result from an activated immune response. Avoiding the allergen and carrying an EpiPen is still recommended for individuals on the medication.
“Targeting the activity of RORγt+ dendritic cells has the potential to work even further upstream to prevent an immune response from first being triggered,” says Wu.
“If that proves to be true, a therapy supporting the activity of this small population of cells might offer lasting tolerance to food allergens.”
Support for this work came from the National Institutes of Health (NIH) and the Swiss National Science Foundation (SNF). This content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.
Source: Washington University in St. Louis
The post Food allergy discovery could pave way for new treatments appeared first on Futurity.